John Hall is an investment analyst in the U.S. Equity Division, working with the health care team on the analysis of drug pipelines and existing therapeutic agents. John is a vice president of T. Rowe Price Group, Inc. He is also a vice president and an Investment Advisory Committee member of the Heath Sciences and Small-Cap Stock Funds. 

John’s investment experience began in 2014 when he joined T. Rowe Price. Prior to this, John worked as an assistant professor of medicine at the Johns Hopkins University, School of Medicine.

John earned a Ph.D. in immunology from the Johns Hopkins University, School of Medicine, and a B.S. in biology from Brown University.